Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectives.

Transl Lung Cancer Res · 2023 · PMC10183392 · PMID 37197636

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Both trials showed a trend towards gefitinib being initially superior to chemotherapy before the crossing of DFS Kaplan-Meier curves to favour chemotherapy after approximately four years ( 32 , 34 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.